The Syncardia™ total artificial heart: In vivo, in vitro, and computational modeling studies

Journal of Biomechanics

Volumn 46, Issue 2, 2013, Pages 266-275

  Slepian, Marvin J ^a,b   Alemu, Yared ^a   Soares, João Silva ^a   G Smith, Richard ^c   Einav, Shmuel ^b,d   Bluestein, Danny ^a  

^a St Francis Hospital The Heart Center   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c SynCardia Systems Inc   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Artificial heart; Computational fluid dynamics; Heart failure; Mechanical circulatory support; Platelet reactivity

Indexed keywords

ACUTE MYOCARDIAL INFARCTION; BI-VENTRICULAR HEARTS; CHRONIC HEART FAILURES; CLOSED LOOPS; COMPUTATIONAL MODELING; CONGENITAL HEART DISEASE; DILATED CARDIOMYOPATHY; ENGINEERING METHODOLOGY; FLOW BEHAVIORS; FLOW CHARACTERISTIC; HEART FAILURE; HEART VALVES; IN-VITRO; IN-VIVO; MECHANICAL CIRCULATORY SUPPORT; SHEAR PROFILE; THROMBOGENICITY; TOTAL ARTIFICIAL HEARTS;

ARTIFICIAL HEART; CARDIOLOGY; COMPUTATIONAL FLUID DYNAMICS; PLATELETS; SHEAR FLOW;

PATIENT TREATMENT;

ARTICLE; ARTIFICIAL HEART; BIOENGINEERING; BIOMECHANICS; BLOOD FLOW; CARDIOMYOPATHY; COMPUTER MODEL; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DEVICE THROMBOGENICITY EMULATION; DIAPHRAGM; DISEASE SEVERITY; FLUID STRUCTURE INTERACTION; FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEART VALVE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METHODOLOGY; PLATELET REACTIVITY; PRIORITY JOURNAL; SHEAR RATE; SIMULATION; THROMBOGENICITY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT RESPONSE; VENTRICULAR ASSIST DEVICE;

ANIMALS; CARDIOMYOPATHY, DILATED; HEART FAILURE; HEART, ARTIFICIAL; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; PULSATILE FLOW;

EID: 84872609069     PISSN: 00219290     EISSN: 18732380     Source Type: Journal    
DOI: 10.1016/j.jbiomech.2012.11.032     Document Type: Article

References (29)

1. Alemu Y., Bluestein D. Flow-induced platelet activation and damage accumulation in a mechanical heart valve: numerical studies. Artifical Organs 2007, 31(9):677-688.
2. Alemu Y., Girdhar G., Xenos M., Sheriff J., Jesty J., Einav S., Bluestein D. Design optimization of a mechanical heart valve for reducing valve thrombogenicity-a case study with ats valve. ASAIO Journal 2010, 56(5):389-396.
3. Apel J., Paul R., Klaus S., Siess T., Reul H. Assessment of hemolysis related quantities in a microaxial blood pump by computational fluid dynamics. Artifical Organs 2001, 25(5):341-347.
4. Artificial heart clinical study approvals, 2012 http://www.cms.gov/Medicare/Medicare-General-Information/MedicareApprovedFacilitie/artificialhearts.html.
5. Bluestein D., Yin W., Affeld K., Jesty J. Flow-induced platelet activation in a mechanical heart valve. Journal of Heart Valve Disease 2004, 13(3):501-508.
6. Copeland J.G., Arabia F.A., Tsau P.H., Nolan P.E., McClellan D., Smith R.G., Slepian M.J. Total artificial hearts: bridge to transplantation. Cardiology Clinics 2003, 21(1):101-113.
7. Copeland J.G., Smith R.G., Arabia F.A., Nolan P.E., McClellan D., Tsau P.H., Sethi G.K., Bose R.K., Banchy M.E., Covington D.L., Slepian M.J. Total artificial heart bridge to transplantation: a 9-year experience with 62 patients. Journal of Heart and Lung Transplantation 2004, 23(7):823-831.
8. Copeland J.G., Smith R.G., Arabia F.A., Nolan P.E., Sethi G.K., Tsau P.H., McClellan D., Slepian M.J. Cardiac replacement with a total artificial heart as a bridge to transplantation. New England Journal of Medicine 2004, 351(9):859-867.
9. Dumont K., Vierendeels J., Kaminsky R., van Nooten G., Verdonck P., Bluestein D. Comparison of the hemodynamic and thrombogenic performance of two bileaflet mechanical heart valves using a cfd/fsi model. Journal of Biomechanical Engineering 2007, 129(4):558-565.
10. Fang J., Mensah G.A., Croft J.B., Keenan N.L. Heart failure-related hospitalization in the US, 1979-2004. Journal of the American College of Cardiology 2008, 52(6):428-434.
11. Fda document 4149b2 01 abiomed instructions for use, 2005.
12. Fda grants hud designation for syncardia's total artificial heart as a destination therapy, 2012. http://www.dicardiology.com/article/fda-grants-hud-designation-syncardia%E2%80%99s-total-artificial-heart-destination-therapy.
13. Hellums J.D. 1993 whitaker lecture: biorheology in thrombosis research. Annals of Biomedical Engineering 1994, 22(5):445-455.
14. Jesty J., Bluestein D. Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: elimination of the feedback activation of platelets by thrombin. Analytical Biochemistry 1999, 272(1):64-70.
15. Kirklin J.K., Naftel D.C. Mechanical circulatory support registering a therapy in evolution. Circulation: Heart Failure 2008, 1(3):200-205.
16. Leprince P., Bonnet N., Rama A., Léger P., Bors V., Levasseur J.P., Szefner J., Vaissier E., Pavie A., Gandjbakhch I. Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: a single-center 15-year experience. Journal of Heart and Lung Transplantation 2003, 22:1296-1303.
17. McMillin C.R. Characterization of hexsyn, a polyolefin rubber. Journal of Biomaterials Applications 1987, 2(1):3-100.
18. Morales D., Khan M., Gottlieb E., Krishnamurthy R., Dreyer W., Adachi I., Implantation of total artificial heart in congenital heart disease. Seminars in Thoracic and Cardiovascular Surgery, in press.
19. Pierson Iii R.N., Johnson F.L. Evolving role of cardiac transplantation for end-stage congestive heart failure. Transplantation Reviews 2005, 19(1):40-46.
20. Premarket approval application (pma) for the syncardia temporary cardiowest total artificial heart (tah-t), 2004. http://www.accessdata.fda.gov/cdrh_docs/pdf3/P030011a.pdf.
21. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D., Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics 2012 update: a report from the american heart association. Circulation 2012, 125(1):e2-e220.
22. Slepian M.J., Copeland J.G. The total artificial heart in refractory cardiogenic shock: saving the patient versus saving the heart. Nature Clinical Practice Cardiovascular Medicine 2008, 5(2):64-65.
23. Slepian M.J., Smith R.G., Copeland J.G. Treatment of advanced heart disease. In: Baughman, K.L., Baumgartner, W.A. (Eds.),. Fundamental and Clinical Cardiology 2006, vol. 56. Taylor & Francis, New York, pp. 473-490.
24. Slepian M.J., Smith R.G., Covington D., Acker M., Arabia F.A., Clayson S., Copeland J.G., DeValeria P.A., Gonzalez-Stawinski G.V., Gregoric I.D., Long J.W., Morris R., Pae W.E., Pagani F.D., Smedira N.G., Smith C., Kasirajan V. Translatable performance with the total artificial heart: the US post-market study. Journal of Heart and Lung Transplantation 2012, 31(4):S88-S89.
25. Summary of safety and effectiveness data, 2004. http://www.accessdata.fda.gov/cdrh_docs/pdf3/P030011b.pdf.
26. Syncardia systems inc. Cardiowest total artificial heart (tah) directions for use, 2004. http://www.fda.gov/ohrms/dockets/ac/04/briefing/4029b1_final.pdf.
27. Xenos M., Girdhar G., Alemu Y., Jesty J., Slepian M., Einav S., Bluestein D. Device thrombogenicity emulator (dte)-design optimization methodology for cardiovascular devices: a study in two bileaflet mhv designs. Journal of Biomechanics 2010.
28. Yin W., Alemu Y., Affeld K., Jesty J., Bluestein D. Flow-induced platelet activation in bileaflet and monoleaflet mechanical heart valves. Annals of Biomedical Engineering 2004, 32(8):1058-1066.
29. Yin W., Gallocher S., Pinchuk L., Schoephoerster R.T., Jesty J., Bluestein D. Flow induced platelet activation in a St. Jude mhv, a trileaflet polymeric heart valve and a St. Jude tissue valve. Artificial Organs 2005, 29(10):826-831.